Pharma & Healthcare
Global Hydroxyprogesterone Caproate Injection Market Research Report 2025
- Apr 16, 25
- ID: 192862
- Pages: 75
- Figures: 69
- Views: 2
The global market for Hydroxyprogesterone Caproate Injection was valued at US$ 271 million in the year 2024 and is projected to reach a revised size of US$ 300 million by 2031, growing at a CAGR of 1.5% during the forecast period.
Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.
Global hydroxyprogesterone caproate injection main manufactuers include AMAG Pharmaceuticals, Mcguff Pharmaceuticals and Aspen, etc., totally holding a share for 97% of the market. North America is the largest market of hydroxyprogesterone caproate injection, with a share about 37%. As for the types of products, it can be divided into 1 ml injection(including 1.1 mL) and 5 ml injection. The most common product is 5 ml injection, with a share over 52%. In terms of applications, it is widely used in hospitals and clinics. The most commom application is in hospitals, with a share over 50%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hydroxyprogesterone Caproate Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hydroxyprogesterone Caproate Injection.
The Hydroxyprogesterone Caproate Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hydroxyprogesterone Caproate Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hydroxyprogesterone Caproate Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
AMAG Pharmaceuticals
Mcguff Pharmaceuticals Inc
Aspen Oss B.V
American Regent, Inc.
Mylan Institutional
Segment by Type
1 mL Injection(Including 1.1 mL)
5 mL Injection
Segment by Application
Hospitals Injection
Clinics Injection
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hydroxyprogesterone Caproate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hydroxyprogesterone Caproate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.
Global hydroxyprogesterone caproate injection main manufactuers include AMAG Pharmaceuticals, Mcguff Pharmaceuticals and Aspen, etc., totally holding a share for 97% of the market. North America is the largest market of hydroxyprogesterone caproate injection, with a share about 37%. As for the types of products, it can be divided into 1 ml injection(including 1.1 mL) and 5 ml injection. The most common product is 5 ml injection, with a share over 52%. In terms of applications, it is widely used in hospitals and clinics. The most commom application is in hospitals, with a share over 50%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hydroxyprogesterone Caproate Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hydroxyprogesterone Caproate Injection.
The Hydroxyprogesterone Caproate Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hydroxyprogesterone Caproate Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hydroxyprogesterone Caproate Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
AMAG Pharmaceuticals
Mcguff Pharmaceuticals Inc
Aspen Oss B.V
American Regent, Inc.
Mylan Institutional
Segment by Type
1 mL Injection(Including 1.1 mL)
5 mL Injection
Segment by Application
Hospitals Injection
Clinics Injection
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hydroxyprogesterone Caproate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hydroxyprogesterone Caproate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Hydroxyprogesterone Caproate Injection Market Overview
1.1 Product Definition
1.2 Hydroxyprogesterone Caproate Injection by Type
1.2.1 Global Hydroxyprogesterone Caproate Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 1 mL Injection(Including 1.1 mL)
1.2.3 5 mL Injection
1.3 Hydroxyprogesterone Caproate Injection by Application
1.3.1 Global Hydroxyprogesterone Caproate Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospitals Injection
1.3.3 Clinics Injection
1.4 Global Hydroxyprogesterone Caproate Injection Market Size Estimates and Forecasts
1.4.1 Global Hydroxyprogesterone Caproate Injection Revenue 2020-2031
1.4.2 Global Hydroxyprogesterone Caproate Injection Sales 2020-2031
1.4.3 Global Hydroxyprogesterone Caproate Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hydroxyprogesterone Caproate Injection Market Competition by Manufacturers
2.1 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hydroxyprogesterone Caproate Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hydroxyprogesterone Caproate Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hydroxyprogesterone Caproate Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hydroxyprogesterone Caproate Injection, Product Type & Application
2.7 Global Key Manufacturers of Hydroxyprogesterone Caproate Injection, Date of Enter into This Industry
2.8 Global Hydroxyprogesterone Caproate Injection Market Competitive Situation and Trends
2.8.1 Global Hydroxyprogesterone Caproate Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hydroxyprogesterone Caproate Injection Players Market Share by Revenue
2.8.3 Global Hydroxyprogesterone Caproate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hydroxyprogesterone Caproate Injection Market Scenario by Region
3.1 Global Hydroxyprogesterone Caproate Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hydroxyprogesterone Caproate Injection Sales by Region: 2020-2031
3.2.1 Global Hydroxyprogesterone Caproate Injection Sales by Region: 2020-2025
3.2.2 Global Hydroxyprogesterone Caproate Injection Sales by Region: 2026-2031
3.3 Global Hydroxyprogesterone Caproate Injection Revenue by Region: 2020-2031
3.3.1 Global Hydroxyprogesterone Caproate Injection Revenue by Region: 2020-2025
3.3.2 Global Hydroxyprogesterone Caproate Injection Revenue by Region: 2026-2031
3.4 North America Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
3.4.1 North America Hydroxyprogesterone Caproate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hydroxyprogesterone Caproate Injection Sales by Country (2020-2031)
3.4.3 North America Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
3.5.1 Europe Hydroxyprogesterone Caproate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hydroxyprogesterone Caproate Injection Sales by Country (2020-2031)
3.5.3 Europe Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hydroxyprogesterone Caproate Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Hydroxyprogesterone Caproate Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hydroxyprogesterone Caproate Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Hydroxyprogesterone Caproate Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
3.7.1 Latin America Hydroxyprogesterone Caproate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hydroxyprogesterone Caproate Injection Sales by Country (2020-2031)
3.7.3 Latin America Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Hydroxyprogesterone Caproate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hydroxyprogesterone Caproate Injection Sales by Type (2020-2031)
4.1.1 Global Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025)
4.1.2 Global Hydroxyprogesterone Caproate Injection Sales by Type (2026-2031)
4.1.3 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2020-2031)
4.2 Global Hydroxyprogesterone Caproate Injection Revenue by Type (2020-2031)
4.2.1 Global Hydroxyprogesterone Caproate Injection Revenue by Type (2020-2025)
4.2.2 Global Hydroxyprogesterone Caproate Injection Revenue by Type (2026-2031)
4.2.3 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2020-2031)
4.3 Global Hydroxyprogesterone Caproate Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hydroxyprogesterone Caproate Injection Sales by Application (2020-2031)
5.1.1 Global Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025)
5.1.2 Global Hydroxyprogesterone Caproate Injection Sales by Application (2026-2031)
5.1.3 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2020-2031)
5.2 Global Hydroxyprogesterone Caproate Injection Revenue by Application (2020-2031)
5.2.1 Global Hydroxyprogesterone Caproate Injection Revenue by Application (2020-2025)
5.2.2 Global Hydroxyprogesterone Caproate Injection Revenue by Application (2026-2031)
5.2.3 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2020-2031)
5.3 Global Hydroxyprogesterone Caproate Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AMAG Pharmaceuticals
6.1.1 AMAG Pharmaceuticals Company Information
6.1.2 AMAG Pharmaceuticals Description and Business Overview
6.1.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product Portfolio
6.1.5 AMAG Pharmaceuticals Recent Developments/Updates
6.2 Mcguff Pharmaceuticals Inc
6.2.1 Mcguff Pharmaceuticals Inc Company Information
6.2.2 Mcguff Pharmaceuticals Inc Description and Business Overview
6.2.3 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product Portfolio
6.2.5 Mcguff Pharmaceuticals Inc Recent Developments/Updates
6.3 Aspen Oss B.V
6.3.1 Aspen Oss B.V Company Information
6.3.2 Aspen Oss B.V Description and Business Overview
6.3.3 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product Portfolio
6.3.5 Aspen Oss B.V Recent Developments/Updates
6.4 American Regent, Inc.
6.4.1 American Regent, Inc. Company Information
6.4.2 American Regent, Inc. Description and Business Overview
6.4.3 American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 American Regent, Inc. Hydroxyprogesterone Caproate Injection Product Portfolio
6.4.5 American Regent, Inc. Recent Developments/Updates
6.5 Mylan Institutional
6.5.1 Mylan Institutional Company Information
6.5.2 Mylan Institutional Description and Business Overview
6.5.3 Mylan Institutional Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mylan Institutional Hydroxyprogesterone Caproate Injection Product Portfolio
6.5.5 Mylan Institutional Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hydroxyprogesterone Caproate Injection Industry Chain Analysis
7.2 Hydroxyprogesterone Caproate Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hydroxyprogesterone Caproate Injection Production Mode & Process Analysis
7.4 Hydroxyprogesterone Caproate Injection Sales and Marketing
7.4.1 Hydroxyprogesterone Caproate Injection Sales Channels
7.4.2 Hydroxyprogesterone Caproate Injection Distributors
7.5 Hydroxyprogesterone Caproate Injection Customer Analysis
8 Hydroxyprogesterone Caproate Injection Market Dynamics
8.1 Hydroxyprogesterone Caproate Injection Industry Trends
8.2 Hydroxyprogesterone Caproate Injection Market Drivers
8.3 Hydroxyprogesterone Caproate Injection Market Challenges
8.4 Hydroxyprogesterone Caproate Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Hydroxyprogesterone Caproate Injection by Type
1.2.1 Global Hydroxyprogesterone Caproate Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 1 mL Injection(Including 1.1 mL)
1.2.3 5 mL Injection
1.3 Hydroxyprogesterone Caproate Injection by Application
1.3.1 Global Hydroxyprogesterone Caproate Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospitals Injection
1.3.3 Clinics Injection
1.4 Global Hydroxyprogesterone Caproate Injection Market Size Estimates and Forecasts
1.4.1 Global Hydroxyprogesterone Caproate Injection Revenue 2020-2031
1.4.2 Global Hydroxyprogesterone Caproate Injection Sales 2020-2031
1.4.3 Global Hydroxyprogesterone Caproate Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hydroxyprogesterone Caproate Injection Market Competition by Manufacturers
2.1 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hydroxyprogesterone Caproate Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hydroxyprogesterone Caproate Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hydroxyprogesterone Caproate Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hydroxyprogesterone Caproate Injection, Product Type & Application
2.7 Global Key Manufacturers of Hydroxyprogesterone Caproate Injection, Date of Enter into This Industry
2.8 Global Hydroxyprogesterone Caproate Injection Market Competitive Situation and Trends
2.8.1 Global Hydroxyprogesterone Caproate Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hydroxyprogesterone Caproate Injection Players Market Share by Revenue
2.8.3 Global Hydroxyprogesterone Caproate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hydroxyprogesterone Caproate Injection Market Scenario by Region
3.1 Global Hydroxyprogesterone Caproate Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hydroxyprogesterone Caproate Injection Sales by Region: 2020-2031
3.2.1 Global Hydroxyprogesterone Caproate Injection Sales by Region: 2020-2025
3.2.2 Global Hydroxyprogesterone Caproate Injection Sales by Region: 2026-2031
3.3 Global Hydroxyprogesterone Caproate Injection Revenue by Region: 2020-2031
3.3.1 Global Hydroxyprogesterone Caproate Injection Revenue by Region: 2020-2025
3.3.2 Global Hydroxyprogesterone Caproate Injection Revenue by Region: 2026-2031
3.4 North America Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
3.4.1 North America Hydroxyprogesterone Caproate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hydroxyprogesterone Caproate Injection Sales by Country (2020-2031)
3.4.3 North America Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
3.5.1 Europe Hydroxyprogesterone Caproate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hydroxyprogesterone Caproate Injection Sales by Country (2020-2031)
3.5.3 Europe Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hydroxyprogesterone Caproate Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Hydroxyprogesterone Caproate Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hydroxyprogesterone Caproate Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Hydroxyprogesterone Caproate Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
3.7.1 Latin America Hydroxyprogesterone Caproate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hydroxyprogesterone Caproate Injection Sales by Country (2020-2031)
3.7.3 Latin America Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Hydroxyprogesterone Caproate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hydroxyprogesterone Caproate Injection Sales by Type (2020-2031)
4.1.1 Global Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025)
4.1.2 Global Hydroxyprogesterone Caproate Injection Sales by Type (2026-2031)
4.1.3 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2020-2031)
4.2 Global Hydroxyprogesterone Caproate Injection Revenue by Type (2020-2031)
4.2.1 Global Hydroxyprogesterone Caproate Injection Revenue by Type (2020-2025)
4.2.2 Global Hydroxyprogesterone Caproate Injection Revenue by Type (2026-2031)
4.2.3 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2020-2031)
4.3 Global Hydroxyprogesterone Caproate Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hydroxyprogesterone Caproate Injection Sales by Application (2020-2031)
5.1.1 Global Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025)
5.1.2 Global Hydroxyprogesterone Caproate Injection Sales by Application (2026-2031)
5.1.3 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2020-2031)
5.2 Global Hydroxyprogesterone Caproate Injection Revenue by Application (2020-2031)
5.2.1 Global Hydroxyprogesterone Caproate Injection Revenue by Application (2020-2025)
5.2.2 Global Hydroxyprogesterone Caproate Injection Revenue by Application (2026-2031)
5.2.3 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2020-2031)
5.3 Global Hydroxyprogesterone Caproate Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AMAG Pharmaceuticals
6.1.1 AMAG Pharmaceuticals Company Information
6.1.2 AMAG Pharmaceuticals Description and Business Overview
6.1.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product Portfolio
6.1.5 AMAG Pharmaceuticals Recent Developments/Updates
6.2 Mcguff Pharmaceuticals Inc
6.2.1 Mcguff Pharmaceuticals Inc Company Information
6.2.2 Mcguff Pharmaceuticals Inc Description and Business Overview
6.2.3 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product Portfolio
6.2.5 Mcguff Pharmaceuticals Inc Recent Developments/Updates
6.3 Aspen Oss B.V
6.3.1 Aspen Oss B.V Company Information
6.3.2 Aspen Oss B.V Description and Business Overview
6.3.3 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product Portfolio
6.3.5 Aspen Oss B.V Recent Developments/Updates
6.4 American Regent, Inc.
6.4.1 American Regent, Inc. Company Information
6.4.2 American Regent, Inc. Description and Business Overview
6.4.3 American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 American Regent, Inc. Hydroxyprogesterone Caproate Injection Product Portfolio
6.4.5 American Regent, Inc. Recent Developments/Updates
6.5 Mylan Institutional
6.5.1 Mylan Institutional Company Information
6.5.2 Mylan Institutional Description and Business Overview
6.5.3 Mylan Institutional Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mylan Institutional Hydroxyprogesterone Caproate Injection Product Portfolio
6.5.5 Mylan Institutional Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hydroxyprogesterone Caproate Injection Industry Chain Analysis
7.2 Hydroxyprogesterone Caproate Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hydroxyprogesterone Caproate Injection Production Mode & Process Analysis
7.4 Hydroxyprogesterone Caproate Injection Sales and Marketing
7.4.1 Hydroxyprogesterone Caproate Injection Sales Channels
7.4.2 Hydroxyprogesterone Caproate Injection Distributors
7.5 Hydroxyprogesterone Caproate Injection Customer Analysis
8 Hydroxyprogesterone Caproate Injection Market Dynamics
8.1 Hydroxyprogesterone Caproate Injection Industry Trends
8.2 Hydroxyprogesterone Caproate Injection Market Drivers
8.3 Hydroxyprogesterone Caproate Injection Market Challenges
8.4 Hydroxyprogesterone Caproate Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Hydroxyprogesterone Caproate Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Hydroxyprogesterone Caproate Injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Hydroxyprogesterone Caproate Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Hydroxyprogesterone Caproate Injection Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Hydroxyprogesterone Caproate Injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Hydroxyprogesterone Caproate Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Hydroxyprogesterone Caproate Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hydroxyprogesterone Caproate Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hydroxyprogesterone Caproate Injection, Product Type & Application
Table 12. Global Key Manufacturers of Hydroxyprogesterone Caproate Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hydroxyprogesterone Caproate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hydroxyprogesterone Caproate Injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hydroxyprogesterone Caproate Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Hydroxyprogesterone Caproate Injection Sales by Region (2020-2025) & (K Units)
Table 18. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2020-2025)
Table 19. Global Hydroxyprogesterone Caproate Injection Sales by Region (2026-2031) & (K Units)
Table 20. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2026-2031)
Table 21. Global Hydroxyprogesterone Caproate Injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2020-2025)
Table 23. Global Hydroxyprogesterone Caproate Injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2026-2031)
Table 25. North America Hydroxyprogesterone Caproate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025) & (K Units)
Table 27. North America Hydroxyprogesterone Caproate Injection Sales by Country (2026-2031) & (K Units)
Table 28. North America Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Hydroxyprogesterone Caproate Injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Hydroxyprogesterone Caproate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025) & (K Units)
Table 32. Europe Hydroxyprogesterone Caproate Injection Sales by Country (2026-2031) & (K Units)
Table 33. Europe Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Hydroxyprogesterone Caproate Injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Hydroxyprogesterone Caproate Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Hydroxyprogesterone Caproate Injection Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Hydroxyprogesterone Caproate Injection Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Hydroxyprogesterone Caproate Injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Hydroxyprogesterone Caproate Injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Hydroxyprogesterone Caproate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Hydroxyprogesterone Caproate Injection Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Hydroxyprogesterone Caproate Injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Hydroxyprogesterone Caproate Injection Sales (K Units) by Type (2020-2025)
Table 51. Global Hydroxyprogesterone Caproate Injection Sales (K Units) by Type (2026-2031)
Table 52. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2020-2025)
Table 53. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2026-2031)
Table 54. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2020-2025)
Table 57. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2026-2031)
Table 58. Global Hydroxyprogesterone Caproate Injection Price (US$/Unit) by Type (2020-2025)
Table 59. Global Hydroxyprogesterone Caproate Injection Price (US$/Unit) by Type (2026-2031)
Table 60. Global Hydroxyprogesterone Caproate Injection Sales (K Units) by Application (2020-2025)
Table 61. Global Hydroxyprogesterone Caproate Injection Sales (K Units) by Application (2026-2031)
Table 62. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2020-2025)
Table 63. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2026-2031)
Table 64. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2020-2025)
Table 67. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2026-2031)
Table 68. Global Hydroxyprogesterone Caproate Injection Price (US$/Unit) by Application (2020-2025)
Table 69. Global Hydroxyprogesterone Caproate Injection Price (US$/Unit) by Application (2026-2031)
Table 70. AMAG Pharmaceuticals Company Information
Table 71. AMAG Pharmaceuticals Description and Business Overview
Table 72. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product
Table 74. AMAG Pharmaceuticals Recent Developments/Updates
Table 75. Mcguff Pharmaceuticals Inc Company Information
Table 76. Mcguff Pharmaceuticals Inc Description and Business Overview
Table 77. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product
Table 79. Mcguff Pharmaceuticals Inc Recent Developments/Updates
Table 80. Aspen Oss B.V Company Information
Table 81. Aspen Oss B.V Description and Business Overview
Table 82. Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product
Table 84. Aspen Oss B.V Recent Developments/Updates
Table 85. American Regent, Inc. Company Information
Table 86. American Regent, Inc. Description and Business Overview
Table 87. American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. American Regent, Inc. Hydroxyprogesterone Caproate Injection Product
Table 89. American Regent, Inc. Recent Developments/Updates
Table 90. Mylan Institutional Company Information
Table 91. Mylan Institutional Description and Business Overview
Table 92. Mylan Institutional Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Mylan Institutional Hydroxyprogesterone Caproate Injection Product
Table 94. Mylan Institutional Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Hydroxyprogesterone Caproate Injection Distributors List
Table 98. Hydroxyprogesterone Caproate Injection Customers List
Table 99. Hydroxyprogesterone Caproate Injection Market Trends
Table 100. Hydroxyprogesterone Caproate Injection Market Drivers
Table 101. Hydroxyprogesterone Caproate Injection Market Challenges
Table 102. Hydroxyprogesterone Caproate Injection Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Hydroxyprogesterone Caproate Injection
Figure 2. Global Hydroxyprogesterone Caproate Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Hydroxyprogesterone Caproate Injection Market Share by Type: 2024 & 2031
Figure 4. 1 mL Injection(Including 1.1 mL) Product Picture
Figure 5. 5 mL Injection Product Picture
Figure 6. Global Hydroxyprogesterone Caproate Injection Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Hydroxyprogesterone Caproate Injection Market Share by Application: 2024 & 2031
Figure 8. Hospitals Injection
Figure 9. Clinics Injection
Figure 10. Global Hydroxyprogesterone Caproate Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Hydroxyprogesterone Caproate Injection Market Size (2020-2031) & (US$ Million)
Figure 12. Global Hydroxyprogesterone Caproate Injection Sales (2020-2031) & (K Units)
Figure 13. Global Hydroxyprogesterone Caproate Injection Average Price (US$/Unit) & (2020-2031)
Figure 14. Hydroxyprogesterone Caproate Injection Report Years Considered
Figure 15. Hydroxyprogesterone Caproate Injection Sales Share by Manufacturers in 2024
Figure 16. Global Hydroxyprogesterone Caproate Injection Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Hydroxyprogesterone Caproate Injection Players: Market Share by Revenue in Hydroxyprogesterone Caproate Injection in 2024
Figure 18. Hydroxyprogesterone Caproate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Hydroxyprogesterone Caproate Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2020-2031)
Figure 21. North America Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2020-2031)
Figure 22. U.S. Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2020-2031)
Figure 25. Europe Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2020-2031)
Figure 26. Germany Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2020-2031)
Figure 33. China Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Taiwan Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Philippines Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2020-2031)
Figure 44. Latin America Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Hydroxyprogesterone Caproate Injection by Type (2020-2031)
Figure 54. Global Revenue Market Share of Hydroxyprogesterone Caproate Injection by Type (2020-2031)
Figure 55. Global Hydroxyprogesterone Caproate Injection Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Hydroxyprogesterone Caproate Injection by Application (2020-2031)
Figure 57. Global Revenue Market Share of Hydroxyprogesterone Caproate Injection by Application (2020-2031)
Figure 58. Global Hydroxyprogesterone Caproate Injection Price (US$/Unit) by Application (2020-2031)
Figure 59. Hydroxyprogesterone Caproate Injection Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Hydroxyprogesterone Caproate Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Hydroxyprogesterone Caproate Injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Hydroxyprogesterone Caproate Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Hydroxyprogesterone Caproate Injection Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Hydroxyprogesterone Caproate Injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Hydroxyprogesterone Caproate Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Hydroxyprogesterone Caproate Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hydroxyprogesterone Caproate Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hydroxyprogesterone Caproate Injection, Product Type & Application
Table 12. Global Key Manufacturers of Hydroxyprogesterone Caproate Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hydroxyprogesterone Caproate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hydroxyprogesterone Caproate Injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hydroxyprogesterone Caproate Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Hydroxyprogesterone Caproate Injection Sales by Region (2020-2025) & (K Units)
Table 18. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2020-2025)
Table 19. Global Hydroxyprogesterone Caproate Injection Sales by Region (2026-2031) & (K Units)
Table 20. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2026-2031)
Table 21. Global Hydroxyprogesterone Caproate Injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2020-2025)
Table 23. Global Hydroxyprogesterone Caproate Injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2026-2031)
Table 25. North America Hydroxyprogesterone Caproate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025) & (K Units)
Table 27. North America Hydroxyprogesterone Caproate Injection Sales by Country (2026-2031) & (K Units)
Table 28. North America Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Hydroxyprogesterone Caproate Injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Hydroxyprogesterone Caproate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025) & (K Units)
Table 32. Europe Hydroxyprogesterone Caproate Injection Sales by Country (2026-2031) & (K Units)
Table 33. Europe Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Hydroxyprogesterone Caproate Injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Hydroxyprogesterone Caproate Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Hydroxyprogesterone Caproate Injection Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Hydroxyprogesterone Caproate Injection Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Hydroxyprogesterone Caproate Injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Hydroxyprogesterone Caproate Injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Hydroxyprogesterone Caproate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Hydroxyprogesterone Caproate Injection Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Hydroxyprogesterone Caproate Injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Hydroxyprogesterone Caproate Injection Sales (K Units) by Type (2020-2025)
Table 51. Global Hydroxyprogesterone Caproate Injection Sales (K Units) by Type (2026-2031)
Table 52. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2020-2025)
Table 53. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2026-2031)
Table 54. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2020-2025)
Table 57. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2026-2031)
Table 58. Global Hydroxyprogesterone Caproate Injection Price (US$/Unit) by Type (2020-2025)
Table 59. Global Hydroxyprogesterone Caproate Injection Price (US$/Unit) by Type (2026-2031)
Table 60. Global Hydroxyprogesterone Caproate Injection Sales (K Units) by Application (2020-2025)
Table 61. Global Hydroxyprogesterone Caproate Injection Sales (K Units) by Application (2026-2031)
Table 62. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2020-2025)
Table 63. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2026-2031)
Table 64. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2020-2025)
Table 67. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2026-2031)
Table 68. Global Hydroxyprogesterone Caproate Injection Price (US$/Unit) by Application (2020-2025)
Table 69. Global Hydroxyprogesterone Caproate Injection Price (US$/Unit) by Application (2026-2031)
Table 70. AMAG Pharmaceuticals Company Information
Table 71. AMAG Pharmaceuticals Description and Business Overview
Table 72. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product
Table 74. AMAG Pharmaceuticals Recent Developments/Updates
Table 75. Mcguff Pharmaceuticals Inc Company Information
Table 76. Mcguff Pharmaceuticals Inc Description and Business Overview
Table 77. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product
Table 79. Mcguff Pharmaceuticals Inc Recent Developments/Updates
Table 80. Aspen Oss B.V Company Information
Table 81. Aspen Oss B.V Description and Business Overview
Table 82. Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product
Table 84. Aspen Oss B.V Recent Developments/Updates
Table 85. American Regent, Inc. Company Information
Table 86. American Regent, Inc. Description and Business Overview
Table 87. American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. American Regent, Inc. Hydroxyprogesterone Caproate Injection Product
Table 89. American Regent, Inc. Recent Developments/Updates
Table 90. Mylan Institutional Company Information
Table 91. Mylan Institutional Description and Business Overview
Table 92. Mylan Institutional Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Mylan Institutional Hydroxyprogesterone Caproate Injection Product
Table 94. Mylan Institutional Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Hydroxyprogesterone Caproate Injection Distributors List
Table 98. Hydroxyprogesterone Caproate Injection Customers List
Table 99. Hydroxyprogesterone Caproate Injection Market Trends
Table 100. Hydroxyprogesterone Caproate Injection Market Drivers
Table 101. Hydroxyprogesterone Caproate Injection Market Challenges
Table 102. Hydroxyprogesterone Caproate Injection Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Hydroxyprogesterone Caproate Injection
Figure 2. Global Hydroxyprogesterone Caproate Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Hydroxyprogesterone Caproate Injection Market Share by Type: 2024 & 2031
Figure 4. 1 mL Injection(Including 1.1 mL) Product Picture
Figure 5. 5 mL Injection Product Picture
Figure 6. Global Hydroxyprogesterone Caproate Injection Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Hydroxyprogesterone Caproate Injection Market Share by Application: 2024 & 2031
Figure 8. Hospitals Injection
Figure 9. Clinics Injection
Figure 10. Global Hydroxyprogesterone Caproate Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Hydroxyprogesterone Caproate Injection Market Size (2020-2031) & (US$ Million)
Figure 12. Global Hydroxyprogesterone Caproate Injection Sales (2020-2031) & (K Units)
Figure 13. Global Hydroxyprogesterone Caproate Injection Average Price (US$/Unit) & (2020-2031)
Figure 14. Hydroxyprogesterone Caproate Injection Report Years Considered
Figure 15. Hydroxyprogesterone Caproate Injection Sales Share by Manufacturers in 2024
Figure 16. Global Hydroxyprogesterone Caproate Injection Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Hydroxyprogesterone Caproate Injection Players: Market Share by Revenue in Hydroxyprogesterone Caproate Injection in 2024
Figure 18. Hydroxyprogesterone Caproate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Hydroxyprogesterone Caproate Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2020-2031)
Figure 21. North America Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2020-2031)
Figure 22. U.S. Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2020-2031)
Figure 25. Europe Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2020-2031)
Figure 26. Germany Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2020-2031)
Figure 33. China Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Taiwan Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Philippines Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2020-2031)
Figure 44. Latin America Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Hydroxyprogesterone Caproate Injection by Type (2020-2031)
Figure 54. Global Revenue Market Share of Hydroxyprogesterone Caproate Injection by Type (2020-2031)
Figure 55. Global Hydroxyprogesterone Caproate Injection Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Hydroxyprogesterone Caproate Injection by Application (2020-2031)
Figure 57. Global Revenue Market Share of Hydroxyprogesterone Caproate Injection by Application (2020-2031)
Figure 58. Global Hydroxyprogesterone Caproate Injection Price (US$/Unit) by Application (2020-2031)
Figure 59. Hydroxyprogesterone Caproate Injection Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232